{ "Starlight Cardiovascular Lifeline Ductus Arteriosus Stent Study for Congenital Heart Disease", "This study is testing a device called the Lifeline Ductus Arteriosus Stent. This stent is designed to keep open a blood vessel in the heart called the ductus arteriosus, which is important for babies with certain congenital heart defects (heart problems present at birth). The study aims to see if the stent is safe and effective for these babies. You might be able to join if your baby is under 6 months old, has a congenital heart defect that relies on this blood vessel for blood flow, and needs a stent of a specific size. The study is looking for 35 participants and its current recruitment status is unclear.", "design": "This is an interventional study, meaning participants will receive the Lifeline Ductus Arterius Stent. It plans to enroll 35 participants.", "commitments": "Eligible subjects will have the Lifeline Ductus Arteriosus Stent implanted. Safety will be measured from implant to 30 days, and effectiveness from implant to 180 days.", "compensation": "Not stated in the trial record.", "follow_up": "Participants will be followed for safety from the time of stent implantation up to 30 days, and for effectiveness up to 180 days after implantation.", }

Study design

Not specified.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.